PT2185155T - Composições farmacêuticas que contêm ligantes recetores de dopamina e métodos de tratamento com a utilização de ligantes recetores de dopamina - Google Patents
Composições farmacêuticas que contêm ligantes recetores de dopamina e métodos de tratamento com a utilização de ligantes recetores de dopaminaInfo
- Publication number
- PT2185155T PT2185155T PT87826020T PT08782602T PT2185155T PT 2185155 T PT2185155 T PT 2185155T PT 87826020 T PT87826020 T PT 87826020T PT 08782602 T PT08782602 T PT 08782602T PT 2185155 T PT2185155 T PT 2185155T
- Authority
- PT
- Portugal
- Prior art keywords
- ligands
- dopamine
- recptor
- treatment
- methods
- Prior art date
Links
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 title 2
- 239000003446 ligand Substances 0.000 title 2
- 102000015554 Dopamine receptor Human genes 0.000 title 1
- 108050004812 Dopamine receptor Proteins 0.000 title 1
- 229960003638 dopamine Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Pregnancy & Childbirth (AREA)
- Addiction (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95369407P | 2007-08-03 | 2007-08-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2185155T true PT2185155T (pt) | 2018-01-04 |
Family
ID=40338740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT87826020T PT2185155T (pt) | 2007-08-03 | 2008-08-04 | Composições farmacêuticas que contêm ligantes recetores de dopamina e métodos de tratamento com a utilização de ligantes recetores de dopamina |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US20090036468A1 (show.php) |
| EP (1) | EP2185155B1 (show.php) |
| JP (1) | JP5460594B2 (show.php) |
| KR (1) | KR101612563B1 (show.php) |
| CN (1) | CN101815519B (show.php) |
| AU (1) | AU2008283989B2 (show.php) |
| CA (1) | CA2695519A1 (show.php) |
| CY (1) | CY1119828T1 (show.php) |
| DK (1) | DK2185155T3 (show.php) |
| EA (1) | EA018064B1 (show.php) |
| ES (1) | ES2653852T3 (show.php) |
| HR (1) | HRP20171908T1 (show.php) |
| HU (1) | HUE036004T2 (show.php) |
| LT (1) | LT2185155T (show.php) |
| MY (1) | MY157192A (show.php) |
| NO (1) | NO2185155T3 (show.php) |
| PL (1) | PL2185155T3 (show.php) |
| PT (1) | PT2185155T (show.php) |
| SI (1) | SI2185155T1 (show.php) |
| WO (1) | WO2009020897A1 (show.php) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9056845B2 (en) | 2008-07-16 | 2015-06-16 | Richter Gedeon Nyrt. | Pharmaceutical formulations containing dopamine receptor ligands |
| WO2011060363A2 (en) * | 2009-11-16 | 2011-05-19 | Auspex Pharmaceuticals, Inc. | Cyclohexyl urea modulators of d2 receptors and/or d3 receptors |
| EP2582701B1 (en) * | 2010-06-18 | 2016-11-02 | Altos Therapeutics, LLC | D2 antagonists, methods of synthesis and methods of use |
| US8912197B2 (en) | 2012-08-20 | 2014-12-16 | Forest Laboratories Holdings Ltd. | Crystalline form of carbamoyl-cyclohexane derivatives |
| US11274087B2 (en) | 2016-07-08 | 2022-03-15 | Richter Gedeon Nyrt. | Industrial process for the preparation of cariprazine |
| HUP1700253A1 (hu) * | 2017-06-13 | 2019-01-28 | Richter Gedeon Nyrt | Szilárd orális gyógyszerkészítmények |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| HU231500B1 (hu) * | 2019-04-10 | 2024-04-28 | Richter Gedeon Nyrt | Karbamoil-ciklohexán származékok autizmus spektrum betegség kezelésére |
| US11547707B2 (en) | 2019-04-10 | 2023-01-10 | Richter Gedeon Nyrt. | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder |
| US12433904B2 (en) | 2019-04-17 | 2025-10-07 | Compass Pathfinder Limited | Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin |
| GEAP202416526A (en) * | 2021-10-28 | 2024-09-25 | Richter Gedeon Nyrt | Treatment of major depressive disorder |
| KR20240122455A (ko) * | 2021-12-13 | 2024-08-12 | 컴퍼스 패쓰파인더 리미티드 | 치료-저항성 우울증의 치료에서 사용하기 위한 실로사이빈 및 보조적 세로토닌 재흡수 저해제 |
| US11931357B2 (en) * | 2022-03-17 | 2024-03-19 | Mapi Pharma Ltd. | Depot systems comprising Cariprazine or salts thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8814057D0 (en) * | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
| ZA977967B (en) * | 1996-09-23 | 1999-03-04 | Lilly Co Eli | Combination therapy for treatment of psychoses |
| US6960577B2 (en) * | 1998-05-22 | 2005-11-01 | Eli Lilly And Company | Combination therapy for treatment of refractory depression |
| US6556540B1 (en) * | 1998-05-29 | 2003-04-29 | Paradyne Corporation | System and method for non-intrusive measurement of service quality in a communications network |
| UA72238C2 (en) * | 1999-10-25 | 2005-02-15 | Lundbeck & Co As H | A method for the preparation of citalopram (variants), s-citalopram, intermediary ketones and a method for the preparation of racemic compounds |
| UA77650C2 (en) * | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
| KR20040030609A (ko) * | 2001-05-01 | 2004-04-09 | 하. 룬트벡 아크티에 셀스카브 | 경상이성체성 순수 에스시탈로프람의 용도 |
| US7030122B2 (en) * | 2002-04-12 | 2006-04-18 | Sepracor Inc. | 1,4-disubstituted piperazine ligands for neurotransmitter receptors |
| NZ536624A (en) * | 2002-06-20 | 2008-04-30 | Lundbeck & Co As H | Combination of an SRI and a GABAB inhibitor for the treatment of a neurological disorder |
| HU227534B1 (en) * | 2003-08-04 | 2011-08-29 | Richter Gedeon Nyrt | (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them |
| CN1845730A (zh) * | 2003-09-04 | 2006-10-11 | H.隆德贝克有限公司 | 5－羟色胺再摄取抑制剂与克塞平的组合 |
| HUP0500170A3 (en) * | 2005-02-03 | 2007-11-28 | Richter Gedeon Nyrt | Piperazine derivatives, process for producing them and pharmaceutical compositions containing them |
| TW200812993A (en) * | 2006-05-02 | 2008-03-16 | Lundbeck & Co As H | New uses of escitalopram |
| HU230748B1 (hu) * | 2007-05-11 | 2018-02-28 | Richter Gedeon Nyrt | Új piperazin só és előállítási eljárása |
-
2008
- 2008-08-04 JP JP2010520238A patent/JP5460594B2/ja active Active
- 2008-08-04 HU HUE08782602A patent/HUE036004T2/hu unknown
- 2008-08-04 MY MYPI2010000523A patent/MY157192A/en unknown
- 2008-08-04 US US12/185,211 patent/US20090036468A1/en not_active Abandoned
- 2008-08-04 PL PL08782602T patent/PL2185155T3/pl unknown
- 2008-08-04 CN CN2008801062563A patent/CN101815519B/zh active Active
- 2008-08-04 HR HRP20171908TT patent/HRP20171908T1/hr unknown
- 2008-08-04 NO NO08782602A patent/NO2185155T3/no unknown
- 2008-08-04 PT PT87826020T patent/PT2185155T/pt unknown
- 2008-08-04 SI SI200831900T patent/SI2185155T1/en unknown
- 2008-08-04 KR KR1020107004638A patent/KR101612563B1/ko active Active
- 2008-08-04 CA CA2695519A patent/CA2695519A1/en not_active Abandoned
- 2008-08-04 EA EA201000280A patent/EA018064B1/ru unknown
- 2008-08-04 ES ES08782602.0T patent/ES2653852T3/es active Active
- 2008-08-04 AU AU2008283989A patent/AU2008283989B2/en active Active
- 2008-08-04 LT LTEP08782602.0T patent/LT2185155T/lt unknown
- 2008-08-04 WO PCT/US2008/072066 patent/WO2009020897A1/en not_active Ceased
- 2008-08-04 DK DK08782602.0T patent/DK2185155T3/en active
- 2008-08-04 EP EP08782602.0A patent/EP2185155B1/en active Active
-
2010
- 2010-09-27 US US12/890,752 patent/US20110015208A1/en not_active Abandoned
-
2011
- 2011-10-10 US US13/269,928 patent/US20120028991A1/en not_active Abandoned
-
2017
- 2017-12-07 CY CY20171101293T patent/CY1119828T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR101612563B1 (ko) | 2016-04-14 |
| AU2008283989B2 (en) | 2013-12-05 |
| AU2008283989A1 (en) | 2009-02-12 |
| MY157192A (en) | 2016-05-13 |
| NO2185155T3 (show.php) | 2018-03-03 |
| CN101815519B (zh) | 2013-08-21 |
| JP5460594B2 (ja) | 2014-04-02 |
| US20090036468A1 (en) | 2009-02-05 |
| HUE036004T2 (hu) | 2018-06-28 |
| US20110015208A1 (en) | 2011-01-20 |
| KR20100059830A (ko) | 2010-06-04 |
| HRP20171908T1 (hr) | 2018-01-26 |
| JP2010535790A (ja) | 2010-11-25 |
| EP2185155B1 (en) | 2017-10-04 |
| US20120028991A1 (en) | 2012-02-02 |
| PL2185155T3 (pl) | 2018-03-30 |
| CA2695519A1 (en) | 2009-02-12 |
| EP2185155A4 (en) | 2012-04-25 |
| CN101815519A (zh) | 2010-08-25 |
| DK2185155T3 (en) | 2018-01-02 |
| EP2185155A1 (en) | 2010-05-19 |
| CY1119828T1 (el) | 2018-06-27 |
| EA018064B1 (ru) | 2013-05-30 |
| EA201000280A1 (ru) | 2010-08-30 |
| SI2185155T1 (en) | 2018-02-28 |
| ES2653852T3 (es) | 2018-02-09 |
| HK1144784A1 (en) | 2011-03-11 |
| WO2009020897A1 (en) | 2009-02-12 |
| LT2185155T (lt) | 2017-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2185155T (pt) | Composições farmacêuticas que contêm ligantes recetores de dopamina e métodos de tratamento com a utilização de ligantes recetores de dopamina | |
| HUS1900009I1 (hu) | Új vegyületek és készítmények, továbbá alkalmazási eljárásaik | |
| AP2975A (en) | Pharmaceutical formulations containing dopamine receptor ligands | |
| EP2291157A4 (en) | COMPOSITIONS AND METHODS FOR TRANSDERING DELIVERY OF PHARMACEUTICAL COMPOUNDS | |
| ZA201008952B (en) | Compositions and methods of use for therapeutic antibodies | |
| EP2328934A4 (en) | T cell Receptor Antibodies and Method of Use | |
| EP2265731A4 (en) | METHODS AND COMPOSITION FOR EVALUATING MEDICATION RESPONSE | |
| EP2205218A4 (en) | ESOMEPRAZOLE-CONTAINING PHARMACEUTICAL COMPOSITION | |
| EP2257543A4 (en) | MUSCARINIC RECEPTOR AGONISTS, COMPOSITIONS, PROCESSING METHODS AND PREPARATION METHODS THEREOF | |
| AP3000A (en) | Slow release pharmaceutical composition made of microparticles | |
| ZA201005530B (en) | Composition for site-specific delivery of imatinib and methods of use | |
| EP2262795A4 (en) | MUSCARIN RECEPTOR AGONISTS, COMPOSITIONS, TREATMENT METHODS ASSOCIATED THEREOF AND METHOD FOR THE PRODUCTION THEREOF | |
| IL198634A0 (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
| IL196031A0 (en) | Polymorph of esomeprazole and process for its preparation | |
| SI1905775T1 (sl) | Teraciklične spojine, postopek za njihovo pripravo, farmacevtski sestavki, ki jih vsebujejo, in njihova uporaba kot ligandi dopaminskih receptorjev | |
| GB0814245D0 (en) | Medicinal use of receptor ligands | |
| GB0710682D0 (en) | Medicinal use of receptor ligands | |
| HU0600832D0 (en) | Silicon composition for vertebroplastical use and process for its preparation |